Recombinant human serum albumin (OsrHSA) has emerged as an important innovation in the sphere of biopharmaceuticals, giving promising breakthroughs across many clinical and industrial purposes. With its structural similarity to naturally derived human serum albumin, OsrHSA supplies a safer, extra dependable alternate for therapeutic use, specially